Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic |
| |
| Authors: | Sue Pavord Jecko Thachil Beverley J. Hunt Mike Murphy Gillian Lowe Mike Laffan Mike Makris Adrian C. Newland Drew Provan John D. Grainger Quentin A. Hill |
| |
| Affiliation: | 1. Department of Haematology, Oxford University Hospitals, Oxford, UK;2. Department of Haematology, Manchester University Foundation Trust, Manchester, UK;3. Department of Haematology, Guy's and St Thomas' Hospital, London, UK;4. Department of Haematology, John Radcliffe Hospital, NHSBT, Oxford, UK;5. Department of Haematology, University Hospitals of Birmingham, Birmingham, UK;6. Department of Haematology, Hammersmith Hospital, Du Cane Road, UK;7. Department of Haematology, Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK;8. Department of Haematology, Barts and the London School of Medicine and Dentistry, London, UK;9. Department of Haematology, Queen Mary University of London, Bart's and The London School of Medicine and Dentistry, Institute of Cell and Molecular Science, London, UK;10. Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK;11. Department of Haematology, St James's University Hospital, Leeds, UK |
| |
| Abstract: | This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum. |
| |
| Keywords: | ITP platelets steroids TPO RA intravenous immunoglobulin thrombosis |
|
|
